🔎 Trials Near Me

Akèy › Artrit Rematoid › North Carolina

Etid klinik pou Artrit Rematoid nan North Carolina

12 etid pou Artrit Rematoid ap chèche patisipan nan sit nan North Carolina.

Vil nan North Carolina

Tèks ofisyèl etid la (Anglè)

EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))

  • Carolina Orthopaedic and Sports Medicine Center, Gastonia
Ap rekrite
Laj 21 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06631638

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

  • Joint And Muscle Research Institute /ID# 277290, Charlotte
  • DJL Clinical Research - Charlotte /ID# 272387, Charlotte
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06972446

Exactech Shoulder Post Market Clinical Follow-up Study

  • Southeastern Sports Medicine and Orthopedics, Asheville
  • Duke Department of Orthopedic Surgery, Durham
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT05603728

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

  • Nkarta Investigational Site, Charlotte
Ap rekriteFaz 1/2
Laj 18 a 75 · Tout sèks · Mizajou Aug 7, 2026 · NCT06733935

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

  • Artiva Investigational Site Charlotte, Charlotte
  • Artiva Investigational Site Charlotte, Charlotte
  • Artiva Investigational Site Statesville, Statesville
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT06991114

A Study of AZD0120 in Autoimmune Diseases

  • Research Site, Chapel Hill
Ap rekriteFaz 1
Laj 18 a 75 · Tout sèks · Mizajou Jul 28, 2026 · NCT07295847

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  • Duke University, Durham
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT07115745

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

  • Duke University, Durham
Ap rekriteEtid obsèvasyon
Laj 18 a 71 · Tout sèks · Mizajou Apr 16, 2026 · NCT07123038

Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis

  • Duke University, Durham
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 19, 2026 · NCT06841562

Improving Hypertension Control in Rheumatoid Arthritis

  • Duke Health System, Durham
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 6, 2026 · NCT05760898

Maternal Autoimmune Disease Research Alliance (MADRA) Registry

  • Duke University, Durham
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Fanm · Mizajou Jan 8, 2026 · NCT03276923

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.